Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Marta Palau Requena

Marta Palau Requena

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Marta Palau Requena

Marta Palau Requena

Marta Palau Requena

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Related news

Membres de la xarxa ReALLNet

A European network facilitates access to precision medicine and clinical trials

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

Equip del projecte PHOENIX

We lead a project to test a more effective and less toxic drug against childhood cancer

The PHOENIX project, involving 13 European institutions, will evaluate for the first time in paediatric patients the drug ibrilatazar from AbilityPharma in a phase I/II clinical trial.

Hospital infantil i de la dona

Hope4Kids to promote more equitable and integrated paediatric palliative care in Europe

The European initiative Hope4Kids will strengthen and harmonise paediatric palliative care across Europe, with the aim of ensuring comprehensive, high-quality care for all children living with life-threatening or life-limiting conditions.

See more

Related professionals

Ana Villar Gomez

Ana Villar Gomez

Main researcher
Pneumology
Read more
Charlene Leraitre

Charlene Leraitre

Predoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Àlex Fonollosa Calduch

Àlex Fonollosa Calduch

Ophtalmology
Read more
Mamadou Fall Sarr

Mamadou Fall Sarr

Postdoctoral researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.